Effect of bioflavonoids on vincristine transport across blood-brain barrier

被引:134
|
作者
Mitsunaga, Y
Takanaga, H
Matsuo, H
Naito, M
Tsuruo, T
Ohtani, H
Sawada, Y
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan
关键词
P-glycoprotein; bioflavonoid; blood-brain barrier; vincristine; protein kinase C;
D O I
10.1016/S0014-2999(00)00180-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several grapefruit juice bioflavonoids, including quercetin, are reported to stimulate P-glycoprotein-mediated drug efflux from cultured tumor cells. To see whether these bioflavonoids alter the permeation of vincristine across the blood-brain barrier, we conducted experiments with cultured mouse brain capillary endothelial cells (MBEC4 cells) in vitro and ddY mice in vivo. The steady-state uptake of [H-3]vincristine by MBEC4 cells was decreased by 10 mu M quercetin, but increased by 50 mu M quercetin. Similarly, the in vivo brain-to-plasma concentration ratio of [H-3]vincristine in ddY mice was decreased by coadministration of 0.1 mg/kg quercetin, but increased by 1.0 mg/kg quercetin. Kaempferol had a similar biphasic effect on the in vitro uptake of [H-3]vincristine. Other aglycones tested (chrysin, flavon, hesperetin, naringenin) increased [H-3]vincristine uptake in the 10-50 mu M range, and glycosides (hesperidin, naringin, rutin) were without effect. We then addressed the mechanism of the concentration-dependent biphasic action of quercetin. Verapamil, a P-glycoprotein inhibitor, inhibited the efflux of [H-3]vincristine from MBEC4 cells, while 10 mu M quercetin significantly stimulated it. The uptake of [H-3]vincristine by MBEC4 cells was increased by inhibitors of protein kinase C, but decreased by phorbol 12-myristate-13-acetate (PMA), as well as by 10 mu M quercetin. The phosphorylation level of P-glycoprotein was increased in the presence of 5 mu M quercetin or 100 nM PMA, but decreased by the protein kinase C inhibitor H7 (1-(5-isoquinolinesulfonyl)-2-methyl-piperazine, 30 mu M). We conclude that low concentrations of quercetin indirectly activate the transport of [H-3]vincristine by enhancing the phosphorylation (and hence activity) of P-glycoprotein, whereas high concentrations of quercetin inhibit P-glycoprotein. Our results indicate that patients taking drugs which are P-glycoprotein substrates may need to restrict their intake of bioflavonoid-containing foods and beverages, such as grapefruit juice. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
  • [31] Facilitating DNAzyme transport across the blood-brain barrier with nanoliposome technology
    Mohammad Javad Hoseinifar
    Faranak Aghaz
    Zahra Asadi
    Peyman Asadi
    Seyed Ershad Nedaei
    Elham Arkan
    Ali Pourmotabbed
    Gholamreza Bahrami
    Tayebeh Pourmotabbed
    Scientific Reports, 15 (1)
  • [32] Transport across the blood-brain barrier: Stereoselectivity and PET-tracers
    Luurtsema, G
    de Lange, ECM
    Lammertsma, AA
    Franssen, EJF
    MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (05) : 306 - 318
  • [33] An in vitro model for vitamin A transport across the human blood-brain barrier
    Est, Chandler B.
    Murphy, Regina M.
    ELIFE, 2023, 12
  • [34] Brain-to-blood active transport of beta-alanine across the blood-brain barrier
    Komura, J
    Tamai, I
    Senmaru, M
    Terasaki, T
    Sai, Y
    Tsuji, A
    FEBS LETTERS, 1997, 400 (01) : 131 - 135
  • [35] Mechanism and developmental changes in iron transport across the blood-brain barrier
    Morgan, EH
    Moos, T
    DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (2-3) : 106 - 113
  • [36] Tunable plasma lipoprotein uptake/transport across the blood-brain barrier
    Suzuki, Kenichiro
    Adiguezel, Denis
    Shinotsuka, Takanori
    Ishibashi, Rei
    Eguchi, Izumi
    Oshima, Hideaki
    Taniguchi, Retsu
    Thalhammer, Stefan
    Takeda, Ken
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2014, 442 : 157 - 163
  • [37] Possible reverse transport of β-amyloid peptide across the blood-brain barrier
    Pluta, R
    Misicka, A
    Barcikowska, M
    Spisacka, S
    Lipkowski, AW
    Januszewski, S
    BRAIN EDEMA XI, 2000, 76 : 73 - 77
  • [38] Lysophospholipids transport across blood-brain barrier in an in vitro reconstruction model
    Tsukahara, Tamotsu
    Sasaki, Masanori
    Haniu, Hisao
    Matsuda, Yoshikazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 676 : 91 - 96
  • [39] Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier
    Wohlfart, Stefanie
    Khalansky, Alexander S.
    Gelperina, Svetlana
    Begley, David
    Kreuter, Joerg
    JOURNAL OF CONTROLLED RELEASE, 2011, 154 (01) : 103 - 107
  • [40] In vitro model for evaluating drug transport across the blood-brain barrier
    Cecchelli, R
    Dehouck, B
    Descamps, L
    Fenart, L
    Buée-Scherrer, V
    Duhem, C
    Lundquist, S
    Rentfel, M
    Torpier, G
    Dehouck, MP
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 165 - 178